Hepatitis B DNA vaccine - Genexine/Crucell
Latest Information Update: 24 Sep 2007
Price :
$50 *
At a glance
- Originator Genexine
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 15 Oct 2004 No development reported - Preclinical for Hepatitis B treatment in South Korea (unspecified route)
- 16 Jul 2002 Preclinical trials in Hepatitis B treatment in South Korea (unspecified route)